News & Media

Winnipeg Company Testing Novel Treatment For Superbug

ImmuniMed Inc. received Canadian and U.S. regulatory approval more than two years ago for a novel treatment for C. diff. (Clostridioides difficile) the number one healthcare acquired super bug. The treatment is essentially antibody infused whole egg powder from hens that have been injected with a C. diff. vaccine.

The treatment has shown very promising results in compassionate trials that have taken place in Australia and the leading Canadian doctor who specializes in treating the illness is on board for the clinical trial.